pI: 8.4627 |
Length (AA): 198 |
MW (Da): 22888 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
5 | 192 | 1ds9 (A) | 1 | 192 | 43.00 | 0 | 1 | 1.49129 | -0.52 |
46 | 181 | 1d0b (A) | 92 | 218 | 35.00 | 0.0000003 | 1 | 1.17967 | -1.23 |
48 | 160 | 4fmz (A) | 250 | 360 | 28.00 | 0.00052 | 1 | 1.07251 | -1.42 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Gametocyte, 22 hs Schizont, Female gametocyte, Male gametocyte. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | 4 hs Ring, Erthyrocytic stages. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Ookinete. | Otto TD |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | 16 hs Trophozoite. | Otto TD |
Yeoh LM | Comparative transcriptomics of female and male gametocytes in Plasmodium berghei and the evolution of sex in alveolates. |
Otto TD | A comprehensive evaluation of rodent malaria parasite genomes and gene expression. |
Ortholog group members (OG5_129790)
Species | Accession | Gene Product |
---|---|---|
Drosophila melanogaster | Dmel_CG8800 | CG8800 gene product from transcript CG8800-RA |
Drosophila melanogaster | Dmel_CG10839 | CG10839 gene product from transcript CG10839-RB |
Echinococcus granulosus | EgrG_000448800 | dynein light chain |
Echinococcus multilocularis | EmuJ_000448800 | dynein light chain |
Giardia lamblia | GL50803_4463 | Dynein light chain |
Homo sapiens | ENSG00000119661 | dynein, axonemal, light chain 1 |
Leishmania braziliensis | LbrM.24.1040 | dynein light chain, putative |
Leishmania donovani | LdBPK_241050.1 | dynein light chain, putative |
Leishmania infantum | LinJ.24.1050 | dynein light chain, putative |
Leishmania major | LmjF.24.1030 | dynein light chain, putative |
Leishmania mexicana | LmxM.24.1030 | dynein light chain, putative |
Mus musculus | ENSMUSG00000042523 | dynein, axonemal, light chain 1 |
Neospora caninum | NCLIV_014880 | hypothetical protein |
Oryza sativa | 4339238 | Os05g0501600 |
Plasmodium berghei | PBANKA_0708100 | dynein light chain 1 |
Plasmodium falciparum | PF3D7_0822500 | dynein light chain 1 |
Plasmodium knowlesi | PKNH_1316500 | dynein light chain 1, putative |
Schistosoma japonicum | Sjp_0216100 | ko:K10411 dynein light chain 1, axonemal, putative |
Schistosoma mansoni | Smp_160330 | dynein light chain |
Schmidtea mediterranea | mk4.008733.01 | Dynein light chain 1, axonemal |
Trypanosoma brucei gambiense | Tbg972.11.6400 | dynein light chain, putative |
Trypanosoma brucei | Tb927.11.5680 | dynein light chain 1, axonemal |
Trypanosoma congolense | TcIL3000_0_24600 | dynein light chain, putative |
Trypanosoma congolense | TcIL3000.11.6050 | dynein light chain, putative |
Trypanosoma cruzi | TcCLB.506203.20 | dynein light chain, putative |
Trypanosoma cruzi | TcCLB.508645.30 | dynein light chain, putative |
Toxoplasma gondii | TGME49_285350 | dynein light chain, putative |
Trichomonas vaginalis | TVAG_447870 | dynein light chain, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.3390 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.3390 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.3390 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.3390 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0708100 this record | Plasmodium berghei | Dispensable | plasmo |
TGME49_285350 | Toxoplasma gondii | Probably non-essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.